Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-058011
Filing Date
2024-07-02
Accepted
2024-07-01 17:47:07
Documents
60
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0208424-10q_bespoke.htm   iXBRL 10-Q 404956
2 CERTIFICATION ea020842401ex31-1_bespoke.htm EX-31.1 9720
3 CERTIFICATION ea020842401ex32-1_bespoke.htm EX-32.1 3722
  Complete submission text file 0001213900-24-058011.txt   3961104

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bspk-20240331.xsd EX-101.SCH 48384
5 XBRL CALCULATION FILE bspk-20240331_cal.xml EX-101.CAL 30603
6 XBRL DEFINITION FILE bspk-20240331_def.xml EX-101.DEF 248291
7 XBRL LABEL FILE bspk-20240331_lab.xml EX-101.LAB 431656
8 XBRL PRESENTATION FILE bspk-20240331_pre.xml EX-101.PRE 239810
63 EXTRACTED XBRL INSTANCE DOCUMENT ea0208424-10q_bespoke_htm.xml XML 291416
Mailing Address 2590 WALNUT ST. DENVER CO 80205
Business Address 2590 WALNUT ST. DENVER CO 80205 855-633-3738
Bespoke Extracts, Inc. (Filer) CIK: 0001409197 (see all company filings)

EIN.: 204743354 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52759 | Film No.: 241092106
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)